Other versions:

(Verbatim name)

ID

(Catalog Number)

ORG

DES

Invalid DOI was provided, please try again

XML
PDF
 
 
Bluesky
Twitter
Facebook
Telegram
Mendeley
Reddit
Notify a colleague
  • ContentsContents
  • Article InfoArticle Info
  • CiteCite
  • MetricsMetrics
  • CommentComment
  • RelatedRelated
  • TabsTabs
  • RefsRefs
  • CitedCited
  • Article title
  • Abstract
  • Keywords
  • Introduction
  • Review methodology
  • The role of copeptin in cardiovascular pathophysiology
  • Copeptin as a prognostic marker in heart failure
  • Evidence summary: acute and chronic HF
    • Acute HF (AHF) applications
    • Chronic HF (CHF) applications
  • Mortality and risk stratification
  • Clinical utility and challenges of copeptin in heart failure management (condensed)
  • Added value over existing biomarkers
  • Integration into risk models & precision care
  • Implementation challenges
    • Standardization and cost effectiveness
    • Assay accessibility
    • Emerging research and future directions
    • Current and upcoming clinical trials
    • Multi-biomarker panels and systems biology
    • AI-driven personalized HF management
    • Genetic and molecular insights
  • Discussion
    • Interpretation of findings
  • Limitations
  • Future directions
  • Conclusion
  • Conflict of interest
  • Author contribution
  • Acknowledgements
  • References
Subscribe to email alerts for current Article's categories
Powered by